Related content

Genetic polymorphisms of ERCC1118, XRCC1399 and GSTP1105 are associated with the clinical outcome of gastric cancer patients receiving oxaliplatinbased adjuvant chemotherapy

By                

Molecular Medicine Reports, Vol. 7, Iss. 6, 2013-01 ,pp. : 1904-1911

Spandidos Publications

Access to resources Recommend Favorite

Phase Ib Study of Drozitumab Combined With First-Line mFOLFOX6 Plus Bevacizumab in Patients with Metastatic Colorectal Cancer

By Rocha Lima Caio M.   Bayraktar Soley   Flores Aurea M.   MacIntyre Jessica   Montero Alberto   Baranda Joaquina C.   Wallmark John   Portera Chia   Raja Rajiv   Stern Howard   Royer-Joo Stephanie   Amler Lukas C.  

Cancer Investigation, Vol. 30, Iss. 10, 2012-12 ,pp. : 727-731

Informa Healthcare

Access to resources Recommend Favorite

Feasibility of mFOLFOX6 as the adjuvant treatment after curative resection of metastases from colorectal cancer in Japanese patients

By Machida Nozomu  

International Journal of Clinical Oncology, Vol. 18, Iss. 2, 2013-04 ,pp. : 279-284

Springer Publishing Company

Access to resources Recommend Favorite

EPAS1 mRNA in plasma from colorectal cancer patients is associated with poor outcome in advanced stages

By                          

Oncology Letters, Vol. 2, Iss. 4, 2011-01 ,pp. : 719-724

Spandidos Publications

Access to resources Recommend Favorite

Death associated protein 1 is correlated with the clinical outcome of patients with colorectal cancer and has a role in the regulation of cell death

By                  

Oncology Reports, Vol. 31, Iss. 1, 2014-01 ,pp. : 175-182

Spandidos Publications

Access to resources Recommend Favorite